Abstract
PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.
| Original language | English (US) |
|---|---|
| Journal | Journal of Glaucoma |
| DOIs | |
| State | Accepted/In press - Aug 26 2016 |
Fingerprint
ASJC Scopus subject areas
- Medicine(all)
- Ophthalmology
Cite this
Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes. / Spratt, Alexander; Blieden, Lauren S.; Dubovy, Sander; Berrocal, Audina; Lee, Richard K.
In: Journal of Glaucoma, 26.08.2016.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Treatment of Recalcitrant Cyclitic Neovascular Pupillary Membranes
AU - Spratt, Alexander
AU - Blieden, Lauren S.
AU - Dubovy, Sander
AU - Berrocal, Audina
AU - Lee, Richard K
PY - 2016/8/26
Y1 - 2016/8/26
N2 - PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.
AB - PURPOSE:: To describe a new approach for the treatment of cyclitic vascularized pupillary membranes. PATIENTS AND METHODS:: A retrospective interventional case series describing 3 patients undergoing a novel interventional treatment at a single institutional center. RESULTS:: This technique allows successful completion of laser membranectomy to create a pupillary aperture. This aperture resulted in improved vision and an enhanced ability to examine for and treat ischemic retinal disease. CONCLUSIONS:: This technique describes a new use for bevacizumab that enables the surgeon to treat recalcitrant and recurrent cyclitic vascularized pupillary membranes.
UR - http://www.scopus.com/inward/record.url?scp=84984662508&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84984662508&partnerID=8YFLogxK
U2 - 10.1097/IJG.0000000000000543
DO - 10.1097/IJG.0000000000000543
M3 - Article
C2 - 27571445
AN - SCOPUS:84984662508
JO - Journal of Glaucoma
JF - Journal of Glaucoma
SN - 1057-0829
ER -